Celldex Provides Corporate Update and Reports First Quarter 2019 Results

    NEXT STORY
    Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference
    PREV STORY
    Digital Pathology Market to Exceed US$ 900 Million by 2026 – TMR
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise

    author_avatar
    NASDAQ Market News

    ContraFect to Present at 2017 World Antimicrobial Resistance Congress

    YONKERS, N.Y., Sept. 11, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    MacroGenics’ MGD006 Granted Orphan Drug Status for AML by FDA

    ROCKVILLE, MD, Jan. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

    author_avatar
    NASDAQ Market News